COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: 20 patients are in the severe stage of the disease who receive plasma therapy with intravenous injection dose twice (200 ml per dose) and in addition to routine med
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: age between 20 to 60 years old
Exclusion criteria
Exclusion criteria: People with a history of other immune, genetic or infectious diseases other than corona Individual suspended but negative for clinical standard covid-19 test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients discharged from the intensive care unit and hospital. Timepoint: Measurement of all standard clinical signs of the disease before the start of plasma therapy and after the start of each injection of plasma over specific intervals of up to one year (if surviving). Method of measurement: Patient file information. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient mortality rate. Timepoint: Recording the mortality rate for one year after starting plasma therapy. Method of measurement: Patient file information. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hossein Hadinedoushan
Yazd University of Medical Sciences
Outcome results
None listed